Understanding the complex regulation of myofibroblast formation by TGFβ-dependent and TGFβ-independent pathways in the pathogenesis of subpleural fibrosis in pulmonary fibrosis is essential for developing more efficacious therapeutics for IPF. The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.